MeCP2 interacts with the super elongation complex to regulate transcription.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Loss-of-function mutations in methyl-CpG binding protein 2 (MECP2) are the primary cause of Rett syndrome.
• The precise molecular mechanisms by which MECP2 regulates gene expression are not fully understood.
• MECP2 is known to bind methylated cytosines on DNA, influencing gene transcription.

Purpose of the Study:

• To identify novel genetic interactors of MECP2.
• To elucidate the role of MECP2 in regulating gene expression, particularly in the context of synaptic plasticity.
• To investigate the functional consequences of MECP2-SEC interactions in vivo.

Main Methods:

• A genetic modifier screen was employed to identify MECP2 interactors.
• Co-immunoprecipitation and chromatin immunoprecipitation assays were used to study protein-protein and protein-DNA interactions.
• Behavioral analyses in mice were conducted to assess the impact of genetic modifications on learning and memory.

Main Results:

• The super elongation complex (SEC), a key transcriptional elongation factor, was identified as a genetic interactor of MECP2.
• MECP2 physically interacts with SEC subunits, specifically binding AFF4, the scaffold protein of the SEC.
• MECP2 facilitates AFF4 and RNA polymerase II binding on a subset of genes involved in synaptic plasticity in the mouse brain.
• Haploinsufficiency of AFF4 exacerbated learning deficits in Mecp2 hypomorphic mice, highlighting a functional link.

Conclusions:

• MECP2 regulates gene expression underlying synaptic plasticity through a novel mechanism involving the super elongation complex.
• This interaction provides new molecular insights into the pathogenesis of Rett syndrome.
• The findings suggest a critical role for the MECP2-SEC pathway in neuronal function and cognitive processes.